Roche Holding AG
- Jurisdiction
Switzerland - LEI
549300U41AUUVOAAOB37 - ISIN
US7711951043 (RHHBY )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€414.81 971.9% undervalued - Fundamental strength relative to industry (Mohanram G-Value)
-
6
/ 7
Profile
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. Read full profile
Fundamentals
- Net revenue
€113.74B - Gross margin
73.6% - EBIT
€33.12B - EBIT margin
29.1% - Net income
€17.49B - Net margin
15.4%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
|
|
|
Stock price
Dividends
- Last dividend amount
-
$1.39 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
70.6%
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Congress transactions
| Name | Transaction date | Value |
|---|---|---|
| Ritchie Torres | August 20, 2025 | $1.00K–$15.00K |
| Josh Gottheimer | May 14, 2025 | $1.00K–$15.00K |
| Bruce Westerman | May 12, 2025 | $1.00K–$15.00K |
| Bruce Westerman | April 16, 2025 | $1.00K–$15.00K |
| Josh Gottheimer | August 15, 2024 | $1.00K–$15.00K |